These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 29359334)
1. Methazolamide-induced toxic epidermal necrolysis in a man carrying HLA-B*59:01: successful treatment with infliximab and glucocorticoid. Jiang YY; Nguyen GH; Jin HZ; Zeng YP Int J Dermatol; 2018 Apr; 57(4):494-496. PubMed ID: 29359334 [No Abstract] [Full Text] [Related]
2. Toxic epidermal necrolysis induced by methazolamide in a Chinese-Korean man carrying HLA-B*59:01. Shu C; Shu D; Tie D; Yu M; Zhang R; Wang T; Dong Q; Sun Q; Mao X; Yan Y Int J Dermatol; 2015 Nov; 54(11):1242-5. PubMed ID: 25970075 [TBL] [Abstract][Full Text] [Related]
3. Methazolamide-induced toxic epidermal necrolysis in a Chinese woman with HLA-B5901. Xu Y; Wu M; Sheng F; Sun Q Indian J Ophthalmol; 2015 Jul; 63(7):623-4. PubMed ID: 26458485 [No Abstract] [Full Text] [Related]
4. HLA-B*59:01: a marker for Stevens-Johnson syndrome/toxic epidermal necrolysis caused by methazolamide in Han Chinese. Yang F; Xuan J; Chen J; Zhong H; Luo H; Zhou P; Sun X; He L; Chen S; Cao Z; Luo X; Xing Q Pharmacogenomics J; 2016 Feb; 16(1):83-7. PubMed ID: 25918017 [TBL] [Abstract][Full Text] [Related]
5. Association between HLA-B*5901 and methazolamide-induced Stevens-Johnson syndrome/toxic epidermal necrolysis: a systematic review and meta-analysis. Tangamornsuksan W; Lohitnavy M Pharmacogenomics J; 2019 Jun; 19(3):286-294. PubMed ID: 30242287 [TBL] [Abstract][Full Text] [Related]
6. HLA-B*5901 is strongly associated with methazolamide-induced Stevens-Johnson syndrome/toxic epidermal necrolysis. Kim SH; Kim M; Lee KW; Kim SH; Kang HR; Park HW; Jee YK Pharmacogenomics; 2010 Jun; 11(6):879-84. PubMed ID: 20504258 [TBL] [Abstract][Full Text] [Related]
7. Association of HLA-C*01:02 with methazolamide-induced toxic epidermal necrolysis. Qiumei G; Zhengju C; Xuefei H; Qu C BMJ Case Rep; 2022 Dec; 15(12):. PubMed ID: 36572447 [TBL] [Abstract][Full Text] [Related]
8. CD8 Jee YK; Kim S; Lee JM; Park HS; Kim SH Clin Exp Allergy; 2017 Jul; 47(7):972-974. PubMed ID: 28295713 [No Abstract] [Full Text] [Related]
9. Unique motif shared by HLA-B*59:01 and HLA-B*55:02 is associated with methazolamide-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese. Jiang M; Yang F; Zhang L; Xu D; Jia Y; Cheng Y; Han S; Wang T; Chen Z; Su Y; Zhu Z; Chen S; Zhang J; Wang L; Yang L; Yang J; Luo X; Xing Q J Eur Acad Dermatol Venereol; 2022 Jun; 36(6):873-880. PubMed ID: 35122707 [TBL] [Abstract][Full Text] [Related]
10. Carbonic anhydrase inhibitor-induced Stevens-Johnson syndrome/toxic epidermal necrolysis leads to extensive cutaneous involvement. Kim S; Yun J; Kang DY; Park HJ; Jo EJ; Jung JW; Park HK; Park JW; Jee YK; Kang HR; Lee JM J Allergy Clin Immunol Pract; 2019; 7(8):2851-2853.e2. PubMed ID: 31128378 [No Abstract] [Full Text] [Related]
11. Association of the HLA-B alleles with carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in the Javanese and Sundanese population of Indonesia: the important role of the HLA-B75 serotype. Yuliwulandari R; Kristin E; Prayuni K; Sachrowardi Q; Suyatna FD; Menaldi SL; Wichukchinda N; Mahasirimongkol S; Cavallari LH Pharmacogenomics; 2017 Dec; 18(18):1643-1648. PubMed ID: 29053440 [TBL] [Abstract][Full Text] [Related]
12. Carbamazepine-induced toxic epidermal necrolysis: the importance of HLA-B*1502 testing in at-risk populations prior to therapy initiation. Sargent B; Juhasz MLW; Joe VC; Lee BA; Rojek NW Int J Dermatol; 2021 Jul; 60(7):907-908. PubMed ID: 33608873 [No Abstract] [Full Text] [Related]
14. Carbamazepine-induced toxic epidermal necrolysis in a patient despite testing negative for HLA B*15:02 allele. Jiang B; Oh CC; Tan KW; Lee HY Ann Acad Med Singap; 2021 Mar; 50(3):258-260. PubMed ID: 33855323 [No Abstract] [Full Text] [Related]
15. HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis. Kaniwa N; Saito Y; Aihara M; Matsunaga K; Tohkin M; Kurose K; Sawada J; Furuya H; Takahashi Y; Muramatsu M; Kinoshita S; Abe M; Ikeda H; Kashiwagi M; Song Y; Ueta M; Sotozono C; Ikezawa Z; Hasegawa R; Pharmacogenomics; 2008 Nov; 9(11):1617-22. PubMed ID: 19018717 [TBL] [Abstract][Full Text] [Related]
16. Medical genetics: a marker for Stevens-Johnson syndrome. Chung WH; Hung SI; Hong HS; Hsih MS; Yang LC; Ho HC; Wu JY; Chen YT Nature; 2004 Apr; 428(6982):486. PubMed ID: 15057820 [TBL] [Abstract][Full Text] [Related]
17. The HLA-B*15:02 allele in a Spanish Romani patient with carbamazepine-induced Stevens-Johnson syndrome. Bellón T; Ramírez E; Borobia AM; Lerma V; Moreno-Hidalgo MA; Laosa O; Aramburu JA; González-Herrada C; de Abajo FJ Pharmacogenomics; 2016 Apr; 17(6):541-5. PubMed ID: 27020614 [TBL] [Abstract][Full Text] [Related]
18. A rare case of topical methazolamide ophthalmic solution causing death due to toxic epidermal necrolysis. Shi L; Li M; Zhang F; Wang B; Yi X; Ding Y; Wang X Clin Exp Dermatol; 2018 Apr; 43(3):326-327. PubMed ID: 29330876 [No Abstract] [Full Text] [Related]